[ET Net News Agency, 28 April 2026] HANSOH PHARMA (03692) fell 2.9% to HK$37.48.
It hits an intra-day low of HK$37.42, dipping below the 100-D SMA of HK$37.651, and an intra-day high of HK$39. The total shares traded was 4.5 million, with a value of HK$171.95m. The active buy/sell ratio is 51:49, with net buying turnover of HK$4.36m. MERRILL LYNCH FE accounts for greatest net responsive buying turnover of HK$14.04m, with volume weighted average price of HK$38.23. UBS accounts for greatest net responsive selling turnover of HK$8.7m, with volume weighted average price of HK$38.225. The stock has fallen a combined 4.8% over the past 2 consecutive trading days.
The Hang Seng Index now fell 266 points, or 1% to 25,658.
Basic Information| Nominal | 37.480 | % Chg | -2.90% |
| High | 39.000 | Low | 37.420 |
| Shares Tr | 4.5m | Turnover | 171.95m |
| 10-D SMA | 39.200 | %H.V | 43.492 |
| 20-D SMA | 38.116 | VWAP | 38.210 |
| 50-D SMA | 35.648 | RSI14 | 50.309 |
Status: Dipping below the 100-D SMA, active buy/sell ratio is 51:49, with net buying turnover of HK$4.36m, falling a combined 4.8% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 37.48 | -2.90 |
| SIHUAN PHARM (00460) | 1.30 | -1.52 |
| GRAND PHARMA (00512) | 6.31 | -0.47 |
| SBP GROUP (01177) | 5.40 | -2.53 |
| HENGRUI PHARMA (01276) | 67.30 | -0.44 |
| LIVZON PHARMA (01513) | 28.36 | +0.57 |
| LUYE PHARMA (02186) | 2.68 | +0.37 |
| FOSUN PHARMA (02196) | 19.80 | +0.46 |
| SH PHARMA (02607) | 11.66 | -0.34 |
| CHINARES PHARMA (03320) | 5.19 | -1.89 |
(ed)
